Leading innovators in isotropically modified heterocyclic compounds for the pharmaceutical industry
Pharmaceutical Technology
FEBRUARY 14, 2023
Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects.
Let's personalize your content